In this case study, a multi-level marketer and distributor of cosmetics engaged CPL Business Consultants to examine the market for Epidermal Growth Factor (EGF) Cosmetics, with a particular focus on the safety and efficacy of the product. 

Objective

The purpose of this study was to assist our client, a direct sales company with a limited product portfolio, in assessing the potential for a particular cosmetic based on Epidermal Growth Factor protein.

The review included scientific literature on safety and available data on efficacy, primarily within the cosmetic area. Other areas included an overview of the regulatory environment to establish if there are any immediately obvious problems and a review of the product competitive arena – US and Europe

Method

In carrying out this study, CPL obtained some cooperation from the manufacturer the client had specified and was able to discuss various aspects relating to the product and company.

In carrying out the study, CPL used its scientific and technical knowledge and contacts to analyse the current situation. Part of the process of analysis and validation was to talk to independent experts in the field identified through our extensive networks. We also used in-house information and databases combined with other publicly available information, such as that obtained from patents and technical literature.

Click to see the contents of the study, or look below for an outline.

Epidermal Growth Factor Cosmetics Market

Objective and Method

Principal Findings

  • Regulation
  • Safety
  • Efficacy
  • Market for Cosmetics & Personal Care

Conclusions

  • Regulation
  • Safety
  • Efficacy and its Competitive Importance
  • Market for Cosmetics and Personal Care

Recommendations

Regulations

  • EU Regulation
    • Banned and restricted substances
    • Approved substances
    • Safety assessment
    • Information to consumers
    • In-market surveillance
    • Safety objectives
    • Safety assessment
    • In-market control
    • Carcinogenic, mutagenic and reprotoxic (CMR) substances
    • Facilitating the management of cosmetics legislation
  • Regulation (EC) NO 1223/2009 OF THE European Parliament and of the Council
    • Chapter II Safety, Responsibility, Free Movement
    • ANNEX I Cosmetic Product Safety Report
  • INCI entry for EGF
  • USA FDA
    • Federal Food, Drug, and Cosmetic Act (FD&C Act)
    • Voluntary Cosmetic Registration Program (VCRP)

Definitions for EGF

  • Function
  • EGF-family
  • Epidermal Growth Factor as a Therapeutic Protein

Scientific Research on Safety (and Efficacy) of EGF

  • Overview
    • Safety
    • Efficacy
  • Publications
    • 39 publications
  • Forum Discussions & Magazine Articles
    • 3 discussions

Patents

Overview of Cosmetic/Personal Care Market

  • Global Market and CAGR
  • Per Capita Spending
  • Buying Patterns and Shifting Trends
  • Division by Sector
  • Growth Forecasts
  • Nature of Competition and Players
  • Barriers to Entry
  • Competition from Medical Devices and Pharmaceuticals Industries
  • Small and Medium-Sized Enterprises
  • Direct Selling Approach
  • Key Policy Issues — Research & Development
  • Intellectual Property / Patents
  • Additional Information
    • Structure of Industry and Production
    • Counterfeit Goods
    • External Trade
    • Revealed Comparative Advantage

Ingredient Supplier Perspective of the Market

  • Introduction
  • Market
  • Structure of the Industry
  • Trends
  • Key Success Factors
  • Major Ingredient Producers
  • Personal Care Products
    • Personal Care Chemical Products and Functions
    • Emollients and Moisturizers
    • Markets
  • Thickening Agents
    • Markets
    • Carriers

Examples of High-End Skincare Products on the Market

News

4 Contacts

16 Tables and 23 Figures

Have a look at our PowerPoint Introduction and Brochure describing deliverables, differentiators and case studies. You can also review eight case studies.

Share this project: